5.84

5.80% 0.32

Armata Pharmaceuticals Inc (ARMP)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$5.52

Offen:

$5.49

24-Stunden-Volumen:

48,029

Relative Volume:

0.33

Marktkapitalisierung:

$217.14M

Einnahmen:

$5.20M

Nettoeinkommen (Verlust:

$-282.61M

KGV:

-0.7522

EPS:

-7.764

Netto-Cashflow:

$-24.47M

1W Leistung:

+8.75%

1M Leistung:

+24.79%

6M Leistung:

-49.70%

1J Leistung:

+96.63%

1-Tages-Spanne:

$5.48

$5.865

1-Wochen-Bereich:

$5.18

$5.865

52-Wochen-Spanne:

$2.762

$16.34

Armata Pharmaceuticals Inc Stock (ARMP) Company Profile

Firmenname

Armata Pharmaceuticals Inc

Sektor

Healthcare (1074)

Branche

Biotechnology (600)

Telefon

310-655-2928

Adresse

4503 Glencoe Avenue, Marina del Rey, CA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-11

Neueste SEC-Einreichungen

ARMP's Discussions on Twitter

Compare ARMP vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ARMP Armata Pharmaceuticals Inc	5.84	164.34M	5.20M	-282.61M	-24.47M	-7.764
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2019-06-19	Eingeleitet	Ladenburg Thalmann	Buy

Armata Pharmaceuticals Inc Aktie (ARMP) Neueste Nachrichten

Aug 20, 2026

Armata (ARMP) Today: Finishes 12.82% Lower at $4.42; Chart View: Price Remains Between $4.20 Support and $4.64 Resistance in the Available RecordLow Volatility Picks - vinanet.vn

Aug 20, 2026

Armata (ARMP) Earnings Report: EPS Falls Short of Its Estimate on the Day; Investor Response: The Market Price Advances 11.18%Earnings Preview - vinanet.vn

Aug 20, 2026

Madison Asset Management LLC Buys New Position in Armata Pharmaceuticals, Inc. $ARMP - MarketBeat

Aug 20, 2026

Aug 19, 2026

Armata (ARMP) Earnings Review: The EPS Result Is Below Expectation under the Current Snapshot; Post-Report Move: Shares Rise 1.79%Return On Equity - vinanet.vn

Aug 19, 2026

Aug 17, 2026

HC Wainwright Forecasts Armata Pharmaceuticals Q3 Earnings - MarketBeat

Aug 17, 2026

Aug 14, 2026

Armata Pharmaceuticals, Inc. Revenue Breakdown – AMEX:ARMP - TradingView

Aug 14, 2026

Aug 13, 2026

H.C. Wainwright Maintains Armata Pharmaceuticals(ARMP.US) With Buy Rating, Maintains Target Price $15 - Moomoo

Aug 13, 2026

Aug 12, 2026

Armata Pharma earnings beat by $0.17, revenue topped estimates - Investing.com

Aug 12, 2026

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Issues Quarterly Earnings Results, Beats Expectations By $0.21 EPS - MarketBeat

Aug 12, 2026

Is Armata Pharmaceuticals Inc (ARMP) Facing Challenges After Q2 - GuruFocus

Aug 12, 2026

Armata Pharmaceuticals, Inc. 2026: Revenue $2.51M, Net income $74.14M, EPS ($0.27) — 10-Q Summary - TradingView

Aug 12, 2026

Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update - PR Newswire

Aug 12, 2026

Aug 08, 2026

ARMP Q1 2026 Earnings: Deep EPS Miss and No Revenue Spotlight Clinical-Stage Cash BurnGuidance Revision Trend - Vinanet

Aug 08, 2026

Aug 07, 2026

[ARMP] Q1 2026 Earnings: Clinical-Stage Biotech Reports Wider-than-Expected Net LossQuarterly Financial Update - vinanet.vn

Aug 07, 2026

Aug 06, 2026

Armata Pharmaceuticals (ARMP) Dips 2% as Shares Approach Key Support at $4.37Breakout Confirmation - vinanet.vn

Aug 06, 2026

Aug 01, 2026

Armata Pharmaceuticals (ARMP) Slips 5% as Biotech Volatility Weighs on Clinical-Stage StockTriple EMA - dars.gov.et

Aug 01, 2026

Armata Pharmaceuticals, Inc. Actuals & Estimates (AMEX:ARMP) - TradingView

Aug 01, 2026

Jul 30, 2026